How Did Niva Bupa Approve Saif Ali Khan’s Rs 36 Lakh Lilavati Hospital Insurance Bill in Hours? Complaint Filed with IRDAI

Mumbai — The Association of Medical Consultants (AMC) has lodged a formal complaint with the Insurance Regulatory and Development Authority of India (IRDAI), raising concerns about the unusually fast approval of actor Saif Ali Khan’s insurance claim at Lilavati Hospital. The claim, reportedly worth ₹36 lakh, was cleared within hours, bypassing standard verification protocols in what is alleged to be a medicolegal case.

AMC Questions Preferential Treatment
The issue came to public attention after a social media post by Nikhil Jha highlighted that the insurance company, Niva Bupa, approved the hospital bill without requesting an FIR copy—a standard requirement for medicolegal cases. Representing over 14,000 medical professionals in Mumbai, the AMC accused the insurance company of providing preferential treatment, raising concerns about discrimination in claim settlements.

Disparities in Claim Processing
According to the AMC, high-profile individuals and corporate policyholders often receive faster claim approvals and higher cashless limits, while ordinary policyholders face procedural delays, limited coverage, and extensive documentation requirements. The association argued that such practices create a two-tier system, undermining fairness and equitable access to medical services.

Key Demands Submitted to IRDAI
In its letter to the regulator, the AMC requested:

• A thorough investigation into the rapid approval of Saif Ali Khan’s insurance claim.
• Equal treatment for all policyholders, irrespective of social or professional status.
• Strict guidelines to prevent discriminatory practices by insurance companies.
• Greater transparency in cashless treatment and claim approval processes.

Call for Reform in Medical Insurance Practices
The AMC emphasized that health insurance should protect all policyholders equally and not favor a select few. The association urged IRDAI to take decisive action to restore public trust and ensure that no individual or group receives undue advantage in claim settlements.

The case has sparked widespread debate over fairness in the insurance sector, with public attention now focused on IRDAI’s response to address the concerns raised by medical professionals and policyholders alike.